Health Condition 1: O244- Gestational diabetes mellitus
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Women diagnosed with gestational diabetes. Prescribed with any form of antidiabetic therapy (insulin and oral hypoglycemics) during pregnancy, and eligible for a switch to other antidiabetic medications based on predefined criteria for blood glucose control. Participants at any stage of gestation during diagnosis. Participants who provide informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Preexisting type-1 and type-2 diabetes and used any antihyperglycemic medications prior to their diagnosis of GDM.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluating the change in blood glucose levels when treated with different antidiabetic medicationsTimepoint: at baseline, 4 weeks and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Observing HbA1c levels, frequency of hypoglycemia & the maternal & fetal outcomes. The risk developed due to the antidiabetic treatment in gestational diabetic patients.Timepoint: at baseline 4weeks & 8weeks | — |
Countries
India
Contacts
Public ContactSushma R
manipal college of pharmaceutical sciences
Outcome results
None listed